Annual Meeting Symposium III: BSFF/ITCF Joint Symposium: Current Management of Fracture Related Infections

Friday, October 25, 2024

8:00 AM – 9:00 AM EDT

Location: 210CDGH

Moderator(s)

Justin M. Haller, MD

Associate Professor
University of Utah
Salt lake City, Utah, United States

Financial Disclosures: Globus Medical: Paid consultant|NewClip Technics: Paid consultant|Orthogrid: Paid consultant|Orthopaedic Trauma Association: Board or committee member|Osteocentric: Paid consultant|Stryker: Paid consultant|Western Orthopedic Association: Board or committee member|

Moderator/Faculty(s)

HP

Hans-Christoph Pape, MD, FIOTA (he/him/his)

Universitätsspital Zürich
Zurich, Zurich, Switzerland

Financial Disclosures: INJURY Journal: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|

Faculty(s)

JW

Joseph C. Wenke, PhD

University of Texas Medical Branch
University of Texas Medical Branch

Financial Disclosures: Journal of Orthopaedic Research: Editorial or governing board|JSOR: Editorial or governing board|
Lucas M. Marchand, MD

University of Utah
University of Utah
Salt Lake City, Utah, United States

Financial Disclosures: AO Trauma North America: Paid presenter or speaker|Synthes: Paid consultant|
PG

Peter V. Giannoudis, MD,PhD,BS

Leeds Gen.L Infirm/Dept of Trauma & Ortho
Leeds Gen.L Infirm/Dept of Trauma & Ortho
Leeds, England, United Kingdom

Financial Disclosures: AO Foundation: Board or committee member|DePuy, A Johnson & Johnson Company: Paid presenter or speaker|ESTROT: Board or committee member|Green Bone: Research support|Injury Journal: Publishing royalties, financial or material support|Injury, BMC Medicine: Editorial or governing board|Smith & Nephew: Paid presenter or speaker|Springer: Publishing royalties, financial or material support|Zimmer: Paid presenter or speaker; Research support|
John Scolaro, MD, MA (he/him/his)

Associate Professor
University of California, Irvine
Orange, California, United States

Financial Disclosures: Globus Medical: IP royalties|Nuvasive: Paid consultant|Restor3d: Stock or stock Options|Smith & Nephew: Paid consultant|Stryker: Paid consultant|Western Orthopaedic Association: Board or committee member|Zimmer: Paid consultant|
HP

Hans-Christoph Pape, MD, FIOTA (he/him/his)

Universitätsspital Zürich
Zurich, Zurich, Switzerland

Financial Disclosures: INJURY Journal: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|

Fracture related infection (FRI) remains prevalent in orthopedic trauma and has a significant impact on patient outcome after injury. There are advancements in our understanding of biofilms, how they impact FRI, and how we can prevent and treat biofilm formation. Additionally, there are evolving technologies for infection prevention and diagnosis that should be reviewed to evaluate if more widespread adoption is warranted. Finally, current treatment strategies for FRI continue to evolve and the latest advancements in managing FRI is critical knowledge for the practicing orthopedic surgeon. The symposium combines the expertise of basic scientists and clinicians from North America and the international community to provide the most current management for FRI.

Learning Objectives:

At the completion of this activity, participants will be able to:

Summarize latest evidence on biofilms and what available antibiotics and adjuvants can be used to prevent biofilm formation.
Review current literature on infection prevention (antibiotics, antibiotic delivery, implant coatings) and diagnosis (next generation DNA sequencing) as well as discuss future studies aimed at preventing infection in high risk patient populations.
Discuss different treatment strategies for acute infection, chronic infection, and infection with associated bone loss.